Credit Suisse’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$5.32M Buy
97,335
+7,892
+9% +$391K 0.01% 1265
2023
Q4
$3.83M Buy
89,443
+15,331
+21% +$477K ﹤0.01% 1498
2023
Q3
$1.93M Sell
74,112
-13,960
-16% -$290K ﹤0.01% 1864
2023
Q2
$2.11M Buy
88,072
+38,718
+78% +$666K ﹤0.01% 1879
2023
Q1
$674K Buy
49,354
+49,284
+70,406% +$784K ﹤0.01% 2563
2022
Q4
$972 Buy
+70
New +$988 ﹤0.01% 3574

Other funds holding BHVN

Credit Suisse's BHVN Position: Q1 2024 in Review

Credit Suisse increased its Biohaven (BHVN) stake by 8.8% in Q1 2024, buying an estimated $391K and bringing the position to 97,335 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #1265.

Credit Suisse first reported a position in BHVN in Q4 2022 and has held it in 6 quarters since. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

  • Credit Suisse held 97,335 shares of Biohaven worth $5.32M as of Q1 2024.
  • Credit Suisse bought 7,892 Biohaven shares in Q1 2024, an estimated $391K.
  • Biohaven made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1265 holding.
  • Credit Suisse first reported a position in Biohaven in Q4 2022 and has held it in 6 quarters since.
  • 243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.